Knowledge Experience Compassion Service
Helping injured people and their families for more than 50 years.
Please see our Avandia information page to learn about the most up-to-date news on the harmful diabetes drug. The attorneys and lawyers at the Branch Law Firm can help you take action against the pharmaceutical giant Glaxo Smith Kline, makers of the diabetes drug Avandia; also known as Rosiglitazone.
Reglan is a prescription drug pushed by pharmaceutical companies to patients to treat Gastroesophageal reflux (GER) Gastroesophageal reflux disease (GERD). Many studies dating back from the 1970s have shown that Reglan is ineffective in resolving GER and GERD. A 2006 study published in Nature Clinical Practice: Gastroenterology & Hepatology concluded that “the evidence base for… read more
NEW MEXICO DANGEROUS DRUGS – AVANDIA RESEARCHERS TIED TO CONFLICTS OF INTERESTS
According to Bloomberg News, 94% of researchers who found positive results from using Avandia had financial ties to pharmaceutical companies. Avandia is a controversial diabetes drug that has been linked to increased sharp increased risk of heart attack and death. Despite the FDA’s issuance of a formal safety alert concerning the risks associated with Avandia,… read more
New Mexico Dangerous Drugs – FDA Conflicts of Interest Compromise Our Safety
Recent allegations of research collaboration between the FDA’s top drug official – Dr. Janet Woodcock – and a pharmaceutical company underscore the potential for conflicts of interests and the high stakes involved in drug marketing. In fact, over the years the FDA has been involved in many conflicts of interest involving dangerous drugs. In August… read more
New Mexico Dangerous Drugs – GlaxoSmithKline Has Duty To Warn Of Avandia Risks
The U.S. Senate Finance Committee has recently issued a report on Avandia, a controversial drug produced by GlaxoSmithKline (“GSK”) to control diabetes. According to the report, GSK knew of possible heart attack risks tied to Avandia many years before the information became public. The report unequivocally states “GSK had a duty to sufficiently warn patients… read more
New Mexico Dangerous Drugs – Wyeth v. Levine Should Apply To Generic Drugs
In a victory for consumers, last Friday the Fifth Circuit Court of Appeals agreed with the lower court that individuals may sue generic drug makers in state court for the “failure to warn” consumers of potentially dangerous side effects from taking their drugs. This decision shadows last March’s Supreme Court decision in Wyeth v. Levine,… read more